{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:02:28Z","timestamp":1778371348491,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Breakthrough varicella (BV) develops in vaccinated persons as a result of infection by wild-type varicella-zoster virus more than 42 days after varicella vaccination. The clinical symptoms are atypical, and clinical diagnosis can be difficult. We investigated laboratory-based diagnostic methods that are relatively simple and highly precise to conduct accurate surveillance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Subjects and Methods:<\/jats:title>\n            <jats:p>We enrolled 42 patients with suspected BV at 2 pediatric hospitals and performed a real-time polymerase chain reaction (PCR) on the skin lesions to confirm the BV diagnosis. We performed PCR on saliva and blood collected during the acute phase, as well as direct fluorescent antibody (DFA) imaging on lesions, and measured varicella-zoster virus immunoglobulin (Ig) G and IgM during the acute and convalescent phases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We confirmed the BV diagnosis in 31 of 42 enrolled patients. The sensitivity of DFA imaging of the lesion, and PCR of saliva and blood were 93.5%, 87.1% and 61.3%, respectively. IgM was detected in 12.9% of patients during the acute phase and in 65.5% during the convalescent phase. IgG increased more than 4-fold in 86.2% of patients between the acute and convalescent phases. The sensitivity and specificity of the assay were 83.9% and 81.8%, respectively, when the diagnostic criteria for IgG were set to greater than 20 during the acute phase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The gold standard of laboratory-based diagnosis of BV has been the PCR of samples taken from lesions. However, DFA of the lesion showed equivalent sensitivity when compared with PCR. PCR using saliva samples is an effective, noninvasive method of diagnosis. We found that high values of IgG during the acute phase can aid in the diagnosis of BV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001475","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T22:29:24Z","timestamp":1482013764000},"page":"560-563","source":"Crossref","is-referenced-by-count":8,"title":["Laboratory Diagnosis of Breakthrough Varicella in Children"],"prefix":"10.1097","volume":"36","author":[{"given":"Masahiro","family":"Watanabe","sequence":"first","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Negoro","sequence":"additional","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Suga","sequence":"additional","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ihara","sequence":"additional","affiliation":[{"name":"Mie National Hospital, Tsu, Mie, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital.","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges.","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/422041","article-title":"An elementary school outbreak of varicella attributed to vaccine failure: policy implications.","volume":"190","author":"Lee","year":"2004","journal-title":"J Infect Dis"},{"key":"R6-20230912","first-page":"389","article-title":"Outbreak of varicella among vaccinated children\u2013Michigan, 2003.","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination.","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jpids\/piv044","article-title":"Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994\u20132012.","volume":"5","author":"Leung","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.","volume":"33","author":"Thomas","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children.","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"R12-20230912","first-page":"20","article-title":"One-dose varicella vaccine effectiveness in an elementary school population and breakthrough varicella.","volume":"120","author":"Watanabe","year":"2016","journal-title":"J Jpn Pediatr Soc"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/341089","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure.","volume":"186","author":"Galil","year":"2002","journal-title":"J Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice.","volume":"344","author":"V\u00e1zquez","year":"2001","journal-title":"N Engl J Med"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine.","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine.","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/653113","article-title":"Evaluation of laboratory methods for diagnosis of varicella.","volume":"51","author":"Leung","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1128\/JVI.73.12.10514-10518.1999","article-title":"Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.","volume":"73","author":"Pevenstein","year":"1999","journal-title":"J Virol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/515638","article-title":"Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis.","volume":"178","author":"Kimura","year":"1998","journal-title":"J Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1128\/jcm.33.10.2792-2795.1995","article-title":"Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions.","volume":"33","author":"Coffin","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/003335491212700608","article-title":"Knowledge, attitudes, and practices for diagnosing breakthrough varicella in the outpatient setting.","volume":"127","author":"Daskalaki","year":"2012","journal-title":"Public Health Rep"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics.","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/infdis\/jis649","article-title":"Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe.","volume":"207","author":"Quinlivan","year":"2013","journal-title":"J Infect Dis"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/527420","article-title":"Varicella-zoster virus in the saliva of patients with herpes zoster.","volume":"197","author":"Mehta","year":"2008","journal-title":"J Infect Dis"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2004.11.007","article-title":"Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.","volume":"119","author":"Chen","year":"2004","journal-title":"Cell"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)82872-0","article-title":"Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.","volume":"116","author":"Tsolia","year":"1990","journal-title":"J Pediatr"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus.","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"issue":"suppl 2","key":"R28-20230912","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1086\/522148","article-title":"Laboratory diagnosis and characteristics of breakthrough varicella in children.","volume":"197","author":"Weinmann","year":"2008","journal-title":"J Infect Dis"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006454-199201000-00006","article-title":"Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response.","volume":"11","author":"White","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients\u2013Arkansas, 2006.","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0000000000000737","article-title":"Failure of a single varicella vaccination to protect children with cancer from life-threatening breakthrough varicella.","volume":"34","author":"Kelley","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology.","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201706000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:07:40Z","timestamp":1694556460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201706000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001475","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}